Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Savient Pharmaceuticals promoted Stephen Smolinski to vice president of marketing. Before joining the drugmaker, he was a marketing director at Roche, where he launched the Actemra rheumatoid arthritis treatment. He previously worked for Johnson & Johnson and Bristol-Myers Squibb.

And we have another winner. Blueprint Medicines hired Christoph Lengauer as chief scientific officer. He was previously vice president and global head of oncology drug discovery and preclinical development, and before that, Lengauer was executive director and senior unit head for oncology discovery at the Novartis Institutes for Biomedical Research.

Medistem added Alan Lewis to its advisory board;
Bristol-Myers Squibb added Gerry Storch to its board;
Formula Pharmaceuticals added Martyn Greenacre to its board;
Sirona Biochem hired Sean Cunliffe as chief business officer;
ICON added Brendan Buckley and Nicholas Alp to its scientific council;
Boehringer Ingelheim promoted Paul Fonteyne to US ceo and president;
Coldstream Labs hired Sholto Maclean as technology transfer manager;
Cerulean Pharm hired Chris Guiffre as sr vp and chief business officer;
Celgene added Richard Barker to its board;
Rapid Pathogen Screening hired Mark Myslinski as ceo;
La Jolla Pharma named George Tidmarsh as ceo and president;
Ventrus added Anthony Altig to its board;
Tris Pharma named Mahdi Fawzi as exec vp of R&D and chief scientific officer;
Pfizer Animal Health promoted Scott Webster to head the Improvest team;
Jazz Pharmaceuticals hired Suzanne Sawochka Hooper as general counsel;
Jazz Pharmaceuticals named Fintan Keegan as sr vp of technical operations;
Jazz Pharmaceuticals named Eunan Maguire sr vp of strategy and corp development;

And now, a separate section just for Novartis…

Novartis named Charlie Hough as strategy head, corporate social responsibility;
Novartis named Michele Galen as head of communications;
Novartis named Jason Browning as head of global internal communications;
Novartis named Eric Althoff head of global external communications;
Novartis named Vas Narasimhan as global head, vaccines development;
Novartis named Brent MacGregor as vaccines head for North America;
Novartis named Carsten Schroeder as global head, diagnostics;
Novartis named Johanna Pattenier as head of public health and market access;
Novartis named Tim Wright as global head of development;
Novartis named Lutz Hegemann as head, global development franchise, established meds;
Novartis named Laurie Letvak as head, global development franchise, critical care;
Novartis named Patrice Matchaba as global head, development operations;
Novartis named Rob Kowalski as head of global development for the US;
Novartis named Miles Harrison as head of global advocacy;
Novartis named Teresa Jose as cfo for Novartis oncology;
Novartis named Alfred Bein is as head of primary care for Europe;
Novartis named Charles Meng as general counsel and chief compliance officer in China;
Novartis named David Lennon as chief marketing officer in China;

Ladder shot thx to Robert CB on Flickr Creative Commons